NO20005387L - 3-(amino- eller aminoalkyl-)pyridinonderivater og deres anvendelse for behandling av HIV-relaterte sykdommer - Google Patents
3-(amino- eller aminoalkyl-)pyridinonderivater og deres anvendelse for behandling av HIV-relaterte sykdommerInfo
- Publication number
- NO20005387L NO20005387L NO20005387A NO20005387A NO20005387L NO 20005387 L NO20005387 L NO 20005387L NO 20005387 A NO20005387 A NO 20005387A NO 20005387 A NO20005387 A NO 20005387A NO 20005387 L NO20005387 L NO 20005387L
- Authority
- NO
- Norway
- Prior art keywords
- aminoalkyl
- hiv
- amino
- treatment
- related diseases
- Prior art date
Links
- 125000004103 aminoalkyl group Chemical group 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
- 150000005299 pyridinones Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8308298P | 1998-04-27 | 1998-04-27 | |
| PCT/EP1999/003023 WO1999055676A1 (en) | 1998-04-27 | 1999-04-27 | 3-(amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of hiv related diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005387D0 NO20005387D0 (no) | 2000-10-26 |
| NO20005387L true NO20005387L (no) | 2000-12-04 |
Family
ID=22176061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005387A NO20005387L (no) | 1998-04-27 | 2000-10-26 | 3-(amino- eller aminoalkyl-)pyridinonderivater og deres anvendelse for behandling av HIV-relaterte sykdommer |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US6451822B1 (no) |
| EP (1) | EP1073637B1 (no) |
| JP (1) | JP2002513004A (no) |
| KR (1) | KR20010087128A (no) |
| CN (1) | CN1303378A (no) |
| AP (1) | AP2000001991A0 (no) |
| AT (1) | ATE334966T1 (no) |
| AU (1) | AU4137899A (no) |
| BG (1) | BG104984A (no) |
| BR (1) | BR9909976A (no) |
| CA (1) | CA2330304A1 (no) |
| CZ (1) | CZ20003978A3 (no) |
| DE (1) | DE69932611T2 (no) |
| EE (1) | EE200000620A (no) |
| HR (1) | HRP20000716A2 (no) |
| HU (1) | HUP0101595A3 (no) |
| ID (1) | ID27502A (no) |
| IL (1) | IL139239A0 (no) |
| MX (1) | MXPA00010490A (no) |
| NO (1) | NO20005387L (no) |
| NZ (1) | NZ508297A (no) |
| PL (1) | PL343685A1 (no) |
| RU (1) | RU2000129671A (no) |
| SK (1) | SK16072000A3 (no) |
| TR (1) | TR200003113T2 (no) |
| WO (1) | WO1999055676A1 (no) |
| ZA (1) | ZA200006037B (no) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436972B1 (en) * | 2000-04-10 | 2002-08-20 | Dalhousie University | Pyridones and their use as modulators of serine hydrolase enzymes |
| US6803370B2 (en) * | 2000-07-21 | 2004-10-12 | Elan Pharmaceuticals, Inc. | Alpha amino acid derivatives—inhibitors of leukocyte adhesion mediated by VLA-4 |
| WO2002024650A2 (en) * | 2000-09-19 | 2002-03-28 | Centre National De La Recherche Scientifique (Cnrs) | Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| US7998986B2 (en) | 2001-12-21 | 2011-08-16 | Exelixis Patent Company Llc | Modulators of LXR |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| US7642277B2 (en) * | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| EP1608629A1 (en) * | 2003-03-24 | 2005-12-28 | F. Hoffmann-La Roche Ag | Benzyl-pyridazinons as reverse transcriptase inhibitors |
| EP1516873A1 (en) * | 2003-09-22 | 2005-03-23 | Facultés Universitaires Notre-Dame de la Paix | 2-pyridinone derivatives, having HIV inhibiting properties |
| TW200613307A (en) * | 2004-05-17 | 2006-05-01 | Tibotec Pharm Ltd | 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones |
| MY148809A (en) * | 2004-07-06 | 2013-05-31 | Eisai R&D Man Co Ltd | Crystals of 1,2-dihydropyridine compound and their production process |
| GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| US9040558B2 (en) * | 2004-12-31 | 2015-05-26 | Dr. Reddy's Laboratories Ltd. | Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors |
| RS53599B1 (sr) | 2005-05-10 | 2015-02-27 | Intermune, Inc. | Piridon derivati za modulaciju stresom aktiviranog sistema proteinskih kinaza |
| JP2009506123A (ja) | 2005-08-29 | 2009-02-12 | バーテックス ファーマシューティカルズ インコーポレイテッド | 非受容体型チロシンキナーゼのｔｅｃファミリーの阻害剤として有用な３，５−二置換ピリド−２−オン |
| DE602006020293D1 (de) | 2005-08-29 | 2011-04-07 | Vertex Pharma | 3,5-disubstituierte pyrid-2-one, die als hemmer der tec-familie von nicht-rezeptor tyrosin-kinasen nützlich sind |
| ATE548363T1 (de) | 2005-08-29 | 2012-03-15 | Vertex Pharma | 3,5-disubstituierte pyrid-2-one, die sich als inhibitoren der tec-familie von nicht-rezeptor- tyrosinkinasen eignen |
| KR20080080373A (ko) * | 2005-12-19 | 2008-09-03 | 신젠타 리미티드 | 살진균제로서 치환된 방향족 헤테로사이클 화합물 |
| AU2008326784B2 (en) * | 2007-11-20 | 2014-04-24 | Merck Sharp & Dohme Corp. | Non-nucleoside reverse transcriptase inhibitors |
| JP5627574B2 (ja) | 2008-06-03 | 2014-11-19 | インターミューン， インコーポレイテッド | 炎症性および線維性疾患を治療するための化合物および方法 |
| WO2010009047A1 (en) * | 2008-07-14 | 2010-01-21 | Korea Research Institute Of Chemical Technology | Pyridone derivatives as non-nucleoside reverse transcriptase inhibitors |
| US8318737B2 (en) | 2009-09-02 | 2012-11-27 | Canthera Therapeutics Inc. | Compounds and compositions for treating cancer |
| US8349832B2 (en) * | 2009-09-02 | 2013-01-08 | Canthera Therapeutics | Compounds and compositions for treating cancer |
| CN102001994B (zh) * | 2010-10-22 | 2014-07-09 | 北京大学 | 吡啶酮类hiv-1逆转录酶抑制剂的制备及其应用 |
| CN103288719A (zh) * | 2012-03-05 | 2013-09-11 | 苏州欧凯医药技术有限公司 | 非核甘艾滋病毒抑制物-吡啶酮类先导体的合成 |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| JO3470B1 (ar) | 2012-10-08 | 2020-07-05 | Merck Sharp & Dohme | مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv |
| CN106459042B (zh) | 2014-04-02 | 2019-06-28 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
| MX389591B (es) | 2014-08-29 | 2025-03-20 | Tes Pharma S R L | INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA |
| MA54549A (fr) * | 2018-12-18 | 2022-03-30 | Merck Sharp & Dohme | Dérivés de pyrimidone en tant qu'agents cytotoxiques sélectifs contre des cellules infectées par le vih |
| CN114026081B (zh) * | 2019-05-22 | 2025-02-11 | 默沙东有限责任公司 | 作为针对hiv感染的细胞的选择性细胞毒性剂的吡啶酮衍生物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5308854A (en) * | 1990-06-18 | 1994-05-03 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
| AU641769B2 (en) * | 1990-06-18 | 1993-09-30 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
| FR2737496B1 (fr) * | 1995-07-31 | 1997-12-19 | Centre Nat Rech Scient | 4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih 1 et 2 |
-
1999
- 1999-04-27 EP EP99924870A patent/EP1073637B1/en not_active Expired - Lifetime
- 1999-04-27 NZ NZ508297A patent/NZ508297A/xx unknown
- 1999-04-27 EE EEP200000620A patent/EE200000620A/xx unknown
- 1999-04-27 AP APAP/P/2000/001991A patent/AP2000001991A0/en unknown
- 1999-04-27 RU RU2000129671/04A patent/RU2000129671A/ru unknown
- 1999-04-27 TR TR2000/03113T patent/TR200003113T2/xx unknown
- 1999-04-27 AU AU41378/99A patent/AU4137899A/en not_active Abandoned
- 1999-04-27 BR BR9909976-4A patent/BR9909976A/pt not_active IP Right Cessation
- 1999-04-27 WO PCT/EP1999/003023 patent/WO1999055676A1/en not_active Ceased
- 1999-04-27 CA CA002330304A patent/CA2330304A1/en not_active Abandoned
- 1999-04-27 IL IL13923999A patent/IL139239A0/xx unknown
- 1999-04-27 DE DE69932611T patent/DE69932611T2/de not_active Expired - Lifetime
- 1999-04-27 US US09/673,635 patent/US6451822B1/en not_active Expired - Fee Related
- 1999-04-27 AT AT99924870T patent/ATE334966T1/de not_active IP Right Cessation
- 1999-04-27 KR KR1020007011918A patent/KR20010087128A/ko not_active Withdrawn
- 1999-04-27 JP JP2000545836A patent/JP2002513004A/ja not_active Withdrawn
- 1999-04-27 SK SK1607-2000A patent/SK16072000A3/sk unknown
- 1999-04-27 ID IDW20002191A patent/ID27502A/id unknown
- 1999-04-27 CN CN99806829A patent/CN1303378A/zh active Pending
- 1999-04-27 HR HR20000716A patent/HRP20000716A2/hr not_active Application Discontinuation
- 1999-04-27 CZ CZ20003978A patent/CZ20003978A3/cs unknown
- 1999-04-27 PL PL99343685A patent/PL343685A1/xx unknown
- 1999-04-27 HU HU0101595A patent/HUP0101595A3/hu unknown
- 1999-04-27 MX MXPA00010490A patent/MXPA00010490A/es unknown
-
2000
- 2000-10-25 ZA ZA200006037A patent/ZA200006037B/en unknown
- 2000-10-26 NO NO20005387A patent/NO20005387L/no not_active Application Discontinuation
- 2000-11-24 BG BG104984A patent/BG104984A/xx unknown
-
2002
- 2002-07-15 US US10/194,240 patent/US6683079B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6683079B2 (en) | 2004-01-27 |
| SK16072000A3 (sk) | 2002-04-04 |
| TR200003113T2 (tr) | 2001-05-21 |
| CZ20003978A3 (cs) | 2001-09-12 |
| DE69932611D1 (de) | 2006-09-14 |
| HUP0101595A3 (en) | 2002-12-28 |
| US6451822B1 (en) | 2002-09-17 |
| BG104984A (en) | 2001-07-31 |
| ID27502A (id) | 2001-04-12 |
| MXPA00010490A (es) | 2002-10-17 |
| PL343685A1 (en) | 2001-08-27 |
| RU2000129671A (ru) | 2004-02-20 |
| KR20010087128A (ko) | 2001-09-15 |
| AP2000001991A0 (en) | 2000-12-31 |
| ATE334966T1 (de) | 2006-08-15 |
| ZA200006037B (en) | 2002-01-25 |
| EE200000620A (et) | 2002-04-15 |
| JP2002513004A (ja) | 2002-05-08 |
| EP1073637B1 (en) | 2006-08-02 |
| NZ508297A (en) | 2002-12-20 |
| IL139239A0 (en) | 2001-11-25 |
| BR9909976A (pt) | 2000-12-26 |
| HRP20000716A2 (en) | 2001-06-30 |
| HUP0101595A2 (hu) | 2001-11-28 |
| DE69932611T2 (de) | 2007-10-11 |
| AU4137899A (en) | 1999-11-16 |
| CA2330304A1 (en) | 1999-11-04 |
| CN1303378A (zh) | 2001-07-11 |
| US20030125340A1 (en) | 2003-07-03 |
| WO1999055676A1 (en) | 1999-11-04 |
| NO20005387D0 (no) | 2000-10-26 |
| EP1073637A1 (en) | 2001-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005387L (no) | 3-(amino- eller aminoalkyl-)pyridinonderivater og deres anvendelse for behandling av HIV-relaterte sykdommer | |
| DK0869126T3 (da) | Dithiolanderivater, deres fremstilling og deres terapeutiske virkning | |
| NO994014D0 (no) | Arylsulfonamider og analoger derav og deres anvendelse for behandling av neurodegenerative sykdommer | |
| NO20004098L (no) | FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser | |
| NO972972D0 (no) | Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse | |
| NO994613D0 (no) | Fremgangsmaate og preparat til behandling av sövn-apne | |
| BR9406209A (pt) | Derivados heterociclicos no tratamento de isquemia e doenças relacionadas | |
| NO20016149L (no) | Indol-derivater og deres anvendelse for behandling av osteporose blant andre applikasjoner | |
| NO943682D0 (no) | Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse | |
| DK1228028T3 (da) | Hydroxyicosatetraenoatsalte, præparater og fremgangsmåder til anvendelse til behandling af öjentörhedslidelser | |
| NO984836L (no) | Substituerte benzylaminer og deres anvendelse for behandling av depresjon | |
| NO955326D0 (no) | Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse | |
| NO20032340D0 (no) | Substituerte derivater av aminofuran-2-yl-eddiksyre og aminotien-2-yl-eddiksyre og deres anvendelse for behandling av migrene og smerte | |
| PT932400E (pt) | Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica | |
| NO992676D0 (no) | 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse | |
| DK0835254T3 (da) | Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse | |
| NO962477L (no) | Benzamidderivater, deres fremstilling og deres terapautiske anvendelse | |
| NO984624L (no) | Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav | |
| NO991581D0 (no) | N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler | |
| NO985974D0 (no) | Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer | |
| NO955242D0 (no) | Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse | |
| NO20022990L (no) | Fremgangsmåte og sammensetning for behandling av smerte | |
| NO950560L (no) | Piperazinderivater, deres fremstilling og terapautiske anvendelse | |
| NO955325L (no) | Propansyrederivater, deres fremstilling og terapeutiske anvendelse | |
| PT1244662E (pt) | Derivado de piridazinoquinolina e metodo para o tratamento da dor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |